AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Isoglipt-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Isomer Life Sciences

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Isoglipt-M 50/500 Tablet

Duo-Diabetic 50/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps mitigate severe diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Duo-Diabetic 50/500mg may be a standalone treatment or used alongside other diabetes therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering blood sugar levels and other medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Maintaining the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, headache, stomach discomfort, and sore throat. Low blood sugar (hypoglycemia) is a potential risk, particularly when combined with insulin or sulfonylureas; proper identification and management of hypoglycemia are essential. This medication isn't universally appropriate. Consult your physician before use if you have pre-existing kidney, liver, or heart conditions, pancreatic issues, or consume excessive alcohol. Pregnant or lactating individuals should seek medical advice prior to use. Interactions with other medications are possible; inform your doctor about all concurrent medications to ensure safety. Alcohol consumption should be limited due to its potential to reduce blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Isoglipt-M 50/500 Tablet

There is no text provided to rephrase.

Uses of Isoglipt-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Isoglipt-M 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Isoglipt-M 50/500 Tablet should be administered with a meal.

Common Side effects of Isoglipt-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Isoglipt-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Isoglipt-M 50/500 Tablet should be administered with a meal.

How Isoglipt-M 50/500 Tablet works:

Isoglipt-M 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Isoglipt-M 50/500 Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Isoglipt-M 50/500 tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against these risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Isoglipt-M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Isoglipt-M 50/500 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Isoglipt-M 50/500 Tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Isoglipt-M 50/500 Tablet is contraindicated in individuals with hepatic impairment and should be strictly avoided. Medical advice is recommended.

What if you forget to take Isoglipt-M 50/500 Tablet :

Should you forget a dose of Isoglipt-M 50/500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Isoglipt-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Isoglipt-M 50/500 Tablet

Isoglipt-M 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Isoglipt-M 50/500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Isoglipt-M 50/500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Isoglipt-M 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Isoglipt-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Sitagliptin/Metformin (Isoglipt-M 50/500) can cause lactic acidosis, a serious, potentially fatal condition resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Isoglipt-M 50/500 Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Isoglipt-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Isoglipt-M 50/500 Tablets are contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Isoglipt-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Isoglipt-M 50/500) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Isoglipt-M 50/500 Tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Isoglipt-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Isoglipt-M 50/500 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Isoglipt-M 50/500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Isoglipt-M 50/500 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (Isoglipt-M 50/500 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Isoglipt-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Isoglipt-M 50/500 Tablet
128
MRP 149
13% off